Chinese mining companies dominate the Congo’s critical mineral production, but a nasty dispute at a cobalt mine shows the country is starting to drive a harder bargain.
Illustration by Tim Marrs
When Dr. Sage Ngoie Mbayo arrived at the gate of the Tenke-Fungurume Mine (TFM), on June 10, he only had one goal: to smooth things over.
The mine is one of the crown jewels in the Democratic Republic of the Congo’s impressive mineral treasure chest. It alone contributes 14 percent of the world's supply of cobalt, a critical input to electric vehicle batteries. But since August 2021, TFM has been locked in something of a tug-of-war between the Congolese government and a state-backed Chinese
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
